Pharmacy and drug forms

503B outsourcing facility

Where a compounded drug parts company with an FDA-approved one, where 503A parts company with 503B, and which accreditation programs tell them apart.

What is 503B outsourcing facility?

An FDA-registered outsourcing facility that can compound in larger volumes without a patient-specific prescription.

It is inspected by FDA and held to full cGMP, which is a materially higher bar than a 503A. For semaglutide and tirzepatide, FDA says outsourcing facilities may not compound either drug from bulk now that the shortages are over, so a seller naming a 503B source for them owes you an explanation.

Related reading: How to Verify an Online GLP-1 Pharmacy: Six Public Checks

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.

Where 503B outsourcing facility comes up on this site

On GLP Watchdog, 503B outsourcing facility comes up in 1 research article and 1 seller review.

Seller reviews that mention it

Other terms under Pharmacy and drug forms

Where the evidence lives